HEALTH● LOW2h ago · Sep 15, 2026, 12:00 PM
LSD could be approved for anxiety in the US in 2027
New Scientist · north america
The psychedelic drug LSD eased anxiety in a late-stage trial, paving the way for a probable approval in the US within the next two years
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH36m agoLiving in deprived areas linked to poorer brain healthEuroNews [en]HEALTH1h agoHospital could have prevented some of nurse's baby killings, judge saysCBS NewsHEALTH2h agoCogent Bio granted third FDA review for lead assetSeeking Alpha TechHEALTH3h agoNumber of people aged 100 or older in Japan exceeds 100,000Irish Times World